A Randomized, Open Label, Multicentered, Parallel Group Clinical Study To Evaluate The Efficacy And Safety of RELEEVA 5 Cramp Relief Herbal Tea, Roll-On Oil And Tablets In The Management Of Primary Dysmenorrhea and Premenstrual Syndrome.

Tirupati Life Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Female participants between the age of 18-45 years (both inclusive) with regular menstrual cycles (21â??35 days)
•who are clinically diagnosed to have primary dysmenorrhea.
•2.Subjects with stable vitals like pulse and blood pressure
•3.Patient should have not participated in any other clinical trial during the past 3 months.
•4.Participants who are willing to give written, signed and dated informed consent to participate in the study.

•1.Secondary dysmenorrhea
•2.Presence of any other Gynaecological diseases.
•3.Pregnant or breastfeeding or planning to become pregnant during the study period.
•4.Known case of Hypersensitivity to Investigational drug content.
•5.Patients suffering from abnormal haematological or biochemical (renal & liver function) blood parameters.
•6.Received any other investigational medicine within 7 days prior to screening which can interfere with investigational product activity
•7.Suffering from any illness which will interfere with present study as decided by clinical investigator
•8.Any condition decided as unfit for study by Clinical investigator

发起方

Tirupati Life Sciences